Studies on the incorporation of eicosapentaenoic acid (EPA) into platelet membrane phospholipids and the effects of EPA supplementation on platelet function, skin bleeding time and blood viscosity in man.
D001760:Bleeding Time; D001792:Blood Platelets / Q000378:metabolism*; D001809:Blood Viscosity / Q000187:drug effects; D015118:Eicosapentaenoic Acid; D005231:Fatty Acids, Unsaturated / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D008563:Membrane Lipids / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism*; D010974:Platelet Aggregation / Q000187:drug effects
D005231:Fatty Acids, Unsaturated; D008563:Membrane Lipids; D010743:Phospholipids; D015118:Eicosapentaenoic Acid